Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
| Image |  |
|---|---|
| Description | scientific article published on 13 July 2017 |
| Author/s |
author: Elliott H Sohn Arlene Drack Chris A. Johnson Stephen R Russell Bart Leroy Edwin M. Stone Katherine A. High |
| Publication date | July 14, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |